Balkees Abderrahman, MD, is the Dallas/Ft. Worth Living Legend Fellow of Cancer Research at the Department of Breast Medical Oncology, the University of Texas MD Anderson Cancer Center, and a PhD trainee under model 'Individuals of Very High Quality' at the Faculty of Biological Sciences, the University of Leeds. Follow Balkees on Twitter at @Balkees_Abd
- [email protected]
A pain-free 1–10 minute breath sampler could enhance and speed up the early detection of a range of cancers, writes Balkees Abderrahman.
By using Oncotype DX test technology, researchers behind the TAILORx trial have proven that invasive and often harmful chemotherapy needn’t be the only option for women with breast cancer.
Digital ingestion tracking system in pills and medication adherence: future advantages and current limitationsSubscription
The US Food and Drug Administration (FDA)’s approval of the first-ever digital pill, Abilify MyCite, an aripiprazole tablet for the treatment of schizophrenia, marks the closest we have come to revolutionising the way the uptake of pills is monitored. On a global scale, the U
Breast cancer prevention trumps cureSubscription
Chemoprevention in British women is inadequateSubscription
Recent blog posts
Balkees Abderrahman highlights the problem of medication non-adherence in the treatment and prevention of breast cancer.